Lipitor, a cholesterol-reducing drug manufactured by Pfizer, has placed its advertising account in review. Valued between $60 and $80 million, Kaplan Thaler, BBDO Worldwide, J. Walter Thompson, and Merkley + Partners, the incumbent, will compete for the work.
Recommend (3) Print RSS
All content published by MediaPost is determined by our editors 100% in the interest of our readers ... independent of advertising, sponsorships or other considerations.